SPORTS. Why march for science when you can run? In the spring, colleagues from the MIVAC research center donned their running shoes and team shirts and participated in three different races: Women’s Run Riga, Göteborgsvarvet, and Blodomloppet. One of the enthusiastic runners from MIVAC is doctoral student Inta Gribonika, who believes that these races are about more than just wellness care for the employees: “We run not only to promote a…
Camilla Hesse first recipient of Internationalization Award
AWARD. Camilla Hesse, a lecturer in the Department of Clinical Chemistry and Transfusion Medicine, has been chosen as the first recipient of a new award recognizing internationalization of teaching and learning at medical faculties in Sweden. The decision to give her the award was made at the national gathering of university deans in Uppsala, Sweden, held recently. “Internationalization has so many benefits, and opens so many doors! When you travel…
Flexible new method for early cancer diagnosis
RESEARCH. Earlier discovery of cancer and greater precision in the treatment process are the objectives of a new method developed by researchers at Sahlgrenska Academy and Boston University. Investments are now being made to roll out this innovation across healthcare and broaden the scope of the research in this field. “We can screen at-risk patient groups, and we also plan to spot the cancer patients who are relapsing so that…
Helena Carén receives funding from the Swedish Childhood Cancer Foundation
GRANT. Helena Carén, who heads a group researching tumour epigenetics at Sahlgrenska Cancer Center, is now having four years of research funded by the Swedish Childhood Cancer Foundation. Helena Carén’s research field, epigenetics, is the link between genes and the environment. The body uses different epigenetic selections to turn on or off different genes. Epigenetics – and thus gene activity – can also be affected by the environment in which…
Early blood signatures of vaccine immunogenicity
NEW STUDY. Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study from a large European research collaboration on systems analysis of immune responses induced by a highly promising vaccine against Ebola in which the University of Gothenburg is participating. This result can inform and…